CYP21A2 c.1451G>C

CYP21A2 c.1451G>C

The CYP21A2 c.1451G>C Novallele Genotyping Assay identifies a single nucleotide change of the CYP21A2 gene. Mutations of the CYP21A2 gene cause 21-hydroxylase deficiency associated with adrenal hyperplasia. 21-hydroxylase deficiency is an inherited disease that affects the adrenal glands and is characterized by arrhythmias, low blood glucose, and low blood sodium levels.


Get in touch

Get in touch with the team

  • :

Product Description

The CYP21A2 c.1451G>C Novallele Genotyping Assay is used to amplify and identify specific genetic polymorphisms or mutations. This assay provides scientists with a simple way to quickly genotype this locus from isolated human genomic DNA. The assay contains functionally-verified oligonucleotide primers and unlabeled probes necessary for PCR and subsequent allele identification by DNA melting. For Research Use Only. Not for use in diagnostic procedures.